This hypothesis is supported by the observation, that only one of the three FHR1-deficient, anti-FH positive SLE patients had hypocomplementemia, and none of them had clinical signs of TMA (Supplementary Table 1). This evidence concerns the gene CFHR1 and systemic lupus erythematosus.